OptHealth Information

See Beyond Your Eyes: Your Window to Whole-Body Health Starts Here OptHealth is a Canadian health-tech company pioneering the use of artificial intelligence for early detection of eye, cardiovascular, and neurological diseases—starting with the retina. Rebranded from Vistel AI and backed by global venture capital, our AI diagnostic systems are clinically validated, CE-certified, and used in over 1,500 medical institutions across Asia and Europe, having served more than 3 million patients to date. By combining advanced fundus imaging with real-time AI analysis, OptHealth enables rapid screening of 13+ eye disorders including diabetic retinopathy, glaucoma, and age-related macular degeneration, within 20 seconds. But we go further: because the retina reflects the health of the heart and brain, our technology unlocks predictive insights into broader systemic health. Now OptHealth in Canada, as our headquarter for North American presence, OptHealth is expanding its reach through both professional healthcare channels and direct-to-consumer models. We are committed to making preventive diagnostics more accessible, empowering individuals to take charge of their health - before symptoms appear.